Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Superimmunity by pan-sarbecovirus nanobodies

Cell Reports(2025)10.1016/j.celrep.2025.116023Source: DataRank Database

Superimmunity by pan-sarbecovirus nanobodies is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Wei Huang ORCID,Hejun Liu,Zhe Sang ORCID,Sham Nambulli ORCID,Jérôme Tubiana ORCID

Live enrichment

PubMed:40601431 PMC:PMC12694714 OpenAlex:https://openalex.org/W4411966508

National Institutes of Health

Grant: RM1GM142002

National Institutes of Health

Grant: 5U24GM129547-03

Pacific Northwest Center for Cryo-EM

National Institutes of Health

Grant: 5R01GM133841-04

Molecular interactions and regulatory events of telomere proteins

National Institutes of Health

Grant: 5R01AI163011-03

Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization

National Institutes of Health

Grant: 1R01CA240993-01

Structural and molecular determinants of protein phosphatase 2A function in lung cancer

National Institutes of Health

Grant: 5R35GM137905-04

Development of the next generation antibody technologies and their applications

National Institutes of Health

Grant: 5RM1GM142002-05

Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://www.cell.com/cell-reports/pdf/S2211-1247(25)00794-6.pdf

publisherhttps://www.cell.com/cell-reports/pdf/S2211-1247(25)00794-6.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124725007946?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725007946?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2025.116023

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responsesvaccines and immunoinformatics approaches0301 basic medicine0206 medical engineering02 engineering and technology03 medical and health sciences

Keywords

Computational biologyBiologyQH301-705.5SARS-CoV-2CorrectionCOVID-19Single-Domain AntibodiesAntibodies, ViralAntibodies, NeutralizingArticleEpitopesSevere acute respiratory syndrome-related coronavirusHumansBiology (General)

Sustainable Development Goals

SDG 3: 3. Good health